Alzheimer's disease, a prevalent form of dementia accounting for 60 % to 80 % of all registered cases, is characterized by disruptions in mental function. Each year, World Alzheimer's Day takes place on September 21 as part of World Alzheimer's Month, starting from 2012. The objective is to raise awareness and address the limited understanding and knowledge surrounding Alzheimer's disease and dementia.
In our commitment to supporting the efforts of medicinal chemistry professionals in combating various forms of dementia, particularly Alzheimer's disease, Life Chemicals provides the following carefully curated screening compound libraries:
- CNS Screening Library: this collection comprises 30,300 potentially CNS-active compounds, chosen based on the latest research findings.
- NMDA Receptor Screening Library: consisting of 1,000 compounds, this library offers potential NMDA channel blockers that have been selected using molecular docking techniques.
- Alzheimer’s Targeted Compound Set: a specialized collection containing 330 analogues of known inhibitors for reported therapeutic targets associated with Alzheimer's disease.
By offering these expertly selected libraries, we strive to contribute to the advancement of drug development projects targeting Alzheimer's disease and other forms of dementia.
Please, contact us at marketing@lifechemicals.com for any additional information and price quotations.
Visit our Website for a detailed product description and take advantage of placing your order online on our E-commerce website.
Download SD files with compound structures directly from our Downloads section
Custom compound selection based on specific parameters can be performed on request, with competitive pricing and the most convenient terms provided.
Figure 1. The Life Chemicals Alzheimer’s Targeted Compound Set provides analogs of known inhibitors of the reported therapeutic targets for Alzheimer's disease, obtained using a 2D fingerprint similarity search.